FONAR CORP
Business
FONAR Corporation designs, manufactures, sells and services magnetic resonance imaging (MRI) scanners, primarily its proprietary Upright® MRI system that enables scanning in multiple patient positions. The company generates revenue from direct MRI equipment sales, service and upgrades for its installed base, and licensing-like arrangements. FONAR operates two reportable segments: medical equipment (MRI scanner design, manufacturing, and service) and physician management and diagnostic services through subsidiary HMCA, which provides non-medical administrative, billing, compliance and operational support to diagnostic imaging facilities and owns/operates six diagnostic imaging centers in Florida.
Summary from 10-K filed 2025-09-22
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Patient fee revenue net of contractual allowances and discounts | 33 | 34 | 30 | 30 | 23 | |
| Product sales | 563,296 | 737,727 | 731,607 | 517,939 | 1 | |
| Service and repair fees | 8 | 7 | 7 | 8 | 8 | |
| Service and repair fees related parties | 180,000 | 139,167 | 110,000 | 110,000 | 110,000 | |
| Management and other fees | 50 | 49 | 49 | 48 | 47 | |
| Management and other fees related medical practices | 12 | 12 | 12 | 12 | 11 | |
| Total Revenues Net | 104 | 103 | 99 | 98 | 90 | |
| Costs related to product sales | 1 | 1 | 852,025 | 416,814 | 1 | |
| Costs related to service and repair fees | 5 | 4 | 3 | 3 | 3 | |
| Costs related to service and repair fees related parties | 323,504 | 144,413 | 44,983 | 43,344 | 39,466 | |
| Costs related to patient fee revenue | 19 | 18 | 16 | 13 | 11 | |
| Costs related to management and other fees | 30 | 29 | 27 | 27 | 25 | |
| Costs related to management and other fees related medical practices | 6 | 6 | 6 | 7 | 6 | |
| Research and development | 2 | 2 | 2 | 1 | 2 | |
| Selling, general and administrative expenses | 30 | 27 | 29 | 24 | 25 | |
| Total Costs and Expenses | 93 | 86 | 84 | 76 | 73 | |
| Income from Operations | 12 | 17 | 15 | 22 | 17 | |
| Interest expense | −25,611 | −76,997 | −50,131 | — | — | |
| Interest income related party | 51,917 | 25,959 | 0 | — | — | |
| Investment income | 2 | 2 | 1 | 247,158 | 311,931 | |
| Other income related party | 0 | 576,857 | 0 | — | — | |
| Other income | 36,195 | 78,763 | −202,720 | 861,087 | 504,450 | |
| Income before Provision for Income Taxes and Noncontrolling Interests | 14 | 19 | 16 | 23 | 18 | |
| Provision for Income Taxes | −3 | −5 | −4 | −6 | −4 | |
| Consolidated Net Income | 11 | 14 | — | — | — | |
| Net Income Noncontrolling Interests | −2 | −4 | −3 | −5 | −3 | |
| Net Income Attributable to FONAR | 8 | 11 | 9 | 12 | 10 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 56 | 56 | 51 | — | — | |
| Short-term investments | 120,494 | 136,102 | 32,799 | 32,326 | 32,177 | |
| Accounts receivable net of allowances for credit losses of $264,212 and $166,049 at June 30, 2025 and 2024, respectively | 5 | 4 | 4 | — | — | |
| Medical receivables | 24 | 24 | 21 | 20 | 18 | |
| Management and other fees receivable net of allowances for credit losses of $14,295,988 and $12,369,921 at June 30, 2025 and 2024, respectively | 43 | 42 | 36 | — | — | |
| Management and other fees receivable related party medical practices net of allowances for credit losses of $7,136,836 and $6,110,399 at June 30, 2025 and 2024, respectively | 10 | 10 | 9 | 9 | 8 | |
| Inventories - net | 3 | 3 | 3 | — | — | |
| Prepaid expenses and other current assets related party | 410,659 | — | — | — | — | |
| Prepaid expenses and other current assets | 2 | 1 | 2 | 1 | 1 | |
| Total Current Assets | 145 | 140 | 126 | 119 | 109 | |
| Accounts receivable long term | 4 | 829,473 | 710,085 | 2 | 3 | |
| Note receivable related party | 554,857 | 581,183 | 0 | — | — | |
| Deferred income tax asset | 6 | 7 | 10 | 13 | 16 | |
| Property and equipment net | 19 | 19 | 22 | 22 | 22 | |
| Right-of-use-asset operating leases | 35 | 38 | 33 | 34 | 30 | |
| Right-of-use-asset finance lease | 376,569 | 530,348 | 729,229 | 928,109 | 1 | |
| Goodwill | 4 | 4 | 4 | 4 | 4 | |
| Other intangible assets net | 3 | 3 | 3 | 4 | 4 | |
| Other assets | 475,680 | 481,147 | 523,506 | 526,269 | 666,514 | |
| Total Assets | 217 | 214 | 201 | 199 | 190 | |
| Current portion of long-term debt | — | 47,002 | 43,767 | — | — | |
| Accounts payable | 1 | 2 | 2 | 2 | 2 | |
| Other current liabilities | 7 | 8 | 5 | 6 | 9 | |
| Operating lease liabilities current portion | 3 | 3 | 4 | 4 | 4 | |
| Finance lease liability current portion | 244,237 | 225,786 | 217,597 | 210,140 | 202,741 | |
| Unearned revenue on service contracts | 5 | 4 | 4 | 4 | 4 | |
| Customer deposits | 354,244 | 443,471 | 602,377 | 361,245 | 731,101 | |
| Total Current Liabilities | 17 | 18 | 16 | 17 | 20 | |
| Unearned revenue on service contracts | 4 | 1 | 760,242 | 2 | 3 | |
| Deferred income tax liability | 321,159 | 371,560 | 394,758 | 215,726 | 238,316 | |
| Due to related party medical practices | 92,663 | 92,663 | 92,663 | — | — | |
| Operating lease liabilities net of current portion | 35 | 37 | 32 | 33 | 29 | |
| Finance lease liability net of current portion | 142,523 | 394,723 | 620,481 | 838,291 | 1 | |
| Long-term debt, less current portion | — | 66,938 | 115,075 | — | — | |
| Other liabilities | 172,853 | 32,026 | 41,750 | 106,541 | 171,331 | |
| Total Long-Term Liabilities | 40 | 40 | 34 | 36 | 34 | |
| Total Liabilities | 57 | 57 | 50 | 53 | 54 | |
| Paid-in capital in excess of par value | 179 | 181 | 183 | 185 | 185 | |
| Accumulated deficit | −5 | −14 | −24 | −34 | −46 | |
| Treasury stock, at cost 34,840 and 45,081 shares of common stock at June 30, 2025 and 2024, respectively | −859,893 | −1 | −515,820 | −675,390 | −675,390 | |
| Total Fonar Corporations Stockholders Equity | 173 | 166 | 158 | 150 | 138 | |
| Noncontrolling interests | −13 | −9 | −7 | −4 | −3 | |
| Total Equity | 160 | 157 | 151 | 146 | 135 | |
| Total Liabilities and Equity | 217 | 214 | 201 | 199 | 190 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Consolidated Net Income | 11 | 14 | — | — | — | |
| Depreciation and amortization | 5 | 5 | 5 | — | — | |
| Provision for credit losses | 3 | 2 | 6 | 1 | 6 | |
| Deferred income tax - net | 823,660 | 3 | 3 | 3 | 3 | |
| Net change in operating right-of-use assets and lease liabilities | −493 | −229,590 | — | — | — | |
| Gain on sale of equipment related party | — | −581,183 | — | — | — | |
| Gain on disposition of fixed assets | — | −75,411 | 213,244 | — | — | |
| Abandoned patents | 55,707 | 225,419 | 0 | — | — | |
| Accounts, medical and management fee receivable(s) | −9 | −12 | −8 | −6 | −12 | |
| Notes receivable | — | 55,200 | −64,532 | — | — | |
| Notes receivable related party | 26,326 | — | — | — | — | |
| Inventories | −97,241 | −145,775 | −209,845 | −696,402 | −14,649 | |
| Prepaid expenses and other current assets | −1 | 266,606 | −438,911 | — | — | |
| Other assets | 5,467 | 42,359 | 2,763 | 129,411 | −18,087 | |
| Accounts payable | −553,562 | 276,669 | 19,685 | −314,766 | −99,224 | |
| Other current liabilities | 3 | 3 | −3 | −4 | 1 | |
| Customer advances | −89,227 | −158,906 | 241,132 | −369,856 | −123,478 | |
| Finance lease liabilities | −79,970 | −217,569 | −210,353 | — | — | |
| Other liabilities | 140,826 | −9,724 | −64,791 | — | — | |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 11 | 14 | 14 | 15 | 19 | |
| Purchases of property and equipment | −4 | −789,961 | −4 | −5 | −4 | |
| Proceeds (Purchase) from short-term investment | 15,608 | −103,303 | −473 | −149 | −293 | |
| Proceeds from sale of equipment | 0 | 75,411 | 0 | — | — | |
| Cost of patents | −25,325 | −32,885 | −119,571 | −87,882 | −163,705 | |
| NET CASH USED IN INVESTING ACTIVITIES | −4 | −850,738 | −4 | −5 | −5 | |
| Repayment of borrowings and finance obligations | −113,940 | −44,902 | −36,615 | −37,239 | −103,335 | |
| Sale of noncontrolling interest | 132,000 | — | — | — | — | |
| Purchase of treasury stock | −2 | −3 | −2 | — | — | |
| Distributions to noncontrolling interests | −6 | −6 | −6 | −6 | −7 | |
| NET CASH USED IN FINANCING ACTIVITIES | −7 | −8 | −8 | −6 | −7 | |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | −7,557 | 5 | 3 | 4 | 8 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is FONAR CORP's CIK number?
FONAR CORP's SEC CIK number is 0000355019 (355019). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find FONAR CORP's SEC filings?
All of FONAR CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did FONAR CORP last report earnings?
FONAR CORP (FONR) most recently filed an earnings 8-K with the SEC on May 12, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001731122-26-000710). This is FONAR CORP's most recent earnings filing of record — not a forecast of its next earnings date.
What is FONAR CORP's most recent earnings 8-K?
FONAR CORP's latest earnings 8-K (Item 2.02) was filed May 12, 2026 under accession 0001731122-26-000710. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View FONAR CORP's latest earnings 8-K →
Look up any company's CIK number →